tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Cash flow

Compare
2,256 Followers

BioCryst Cash Flow

BCRX's free cash flow for Q4 2024 was $-5.89M. For the 2024 fiscal year, BCRX's free cash flow was decreased by $44.16M and operating cash flow was $-5.21M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -52.02M$ -95.14M$ -161.85M$ -142.16M$ -137.22M
Investing Cash Flow
$ 52.59M$ -131.50M$ -128.24M$ 15.80M$ -6.86M
Financing Cash Flow
$ -5.76M$ 32.48M$ 88.03M$ 359.67M$ 302.70M
End Cash Position
$ 106.32M$ 112.45M$ 306.24M$ 507.73M$ 274.35M
Free Cash Flow
$ -53.14M$ -97.31M$ -163.20M$ -144.54M$ -137.73M
Currency in USD

BioCryst Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis